Greedy Insider · Filing
ASPE · New 13D · ARCH Venture Fund X, L.P. and affiliates
ARCH Venture Fund X, L.P. and affiliates reported a 12.9% stake in ASPEN NEUROSCIENCE, INC. (ASPE) in a Schedule 13D filed on Nov 9, 2026, triggered by an event on Nov 2, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001193125-26-454047